A. Eden Evins

Zitiert von

	Alle	Seit 2019
Zitate	14520	5468
h-index	62	38
i10-index	145	112

1100

550

275

825

20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202442 58 98 135 221 335 388 517 483 533 520 653 702 666 685 860 899 901 1053 1062 1026 1005 1032 268

Öffentlicher Zugriff

Alle anzeigen

117 Artikel

9 Artikel

verfügbar

nicht verfügbar

Basierend auf Fördermandaten

Koautoren

Donald GoffNYU School of MedicineBestätigte E-Mail-Adresse bei nyumc.org
David Alan SchoenfeldProfessor of MedicineBestätigte E-Mail-Adresse bei partners.org
Jodi GilmanMassachusetts General Hospital/Harvard Medical SchoolBestätigte E-Mail-Adresse bei partners.org
Fava, MMassachusetts General Hospital and Harvard Medical SchoolBestätigte E-Mail-Adresse bei partners.org
Randi SchusterMassachusetts General Hospital/Harvard Medical SchoolBestätigte E-Mail-Adresse bei mgh.harvard.edu
Luke E. StoeckelDirector, Neuropsychology of Aging and Early AD/ADRD Program, NIA/NIHBestätigte E-Mail-Adresse bei nih.gov
Nancy A. RigottiProfessor of Medicine, Harvard Medical SchoolBestätigte E-Mail-Adresse bei partners.org
Diego A. PizzagalliHarvard Medical SchoolBestätigte E-Mail-Adresse bei mclean.harvard.edu
Amy JanesPrincipal Investigator, National Institute on Drug Abuse - Intramural Research ProgramBestätigte E-Mail-Adresse bei nih.gov
Xiaoduo FanUniversity of Massachusetts Medical SchoolBestätigte E-Mail-Adresse bei umassmed.edu
Marc J. KaufmanMcLean Hospital Harvard Medical SchoolBestätigte E-Mail-Adresse bei mclean.harvard.edu
Robert M. Anthenelli, M.D.Professor of Psychiatry, University of California, San DiegoBestätigte E-Mail-Adresse bei ucsd.edu
Robert WestUniversity College LondonBestätigte E-Mail-Adresse bei ucl.ac.uk
Blaise FrederickAssociate Professor of Psychiatry, Harvard Medical SchoolBestätigte E-Mail-Adresse bei mclean.harvard.edu
Vanessa CalderonUniversity of California, Los AngelesBestätigte E-Mail-Adresse bei g.ucla.edu
Avram HolmesDepartment of Psychiatry, Center for Brain Health, Rutgers UniversityBestätigte E-Mail-Adresse bei rutgers.edu
Bettina HoeppnerAssistant Professor, Massachusetts General Hospital, Harvard Medical SchoolBestätigte E-Mail-Adresse bei brown.edu
Eric AchtyesWMU Homer Stryker M.D. School of MedicineBestätigte E-Mail-Adresse bei wmed.edu
John F. Kelly, Ph.D.Elizabeth R. Spallin Professor of Psychiatry in the Field of Addiction Medicine, HarvardBestätigte E-Mail-Adresse bei mgh.harvard.edu
Susan whitfield-gabrieliMITBestätigte E-Mail-Adresse bei mit.edu

Folgen

A. Eden Evins

Mass General Hospital and Harvard Medical School

Bestätigte E-Mail-Adresse bei mgh.harvard.edu - Startseite

addiction medicine nicotine and cannabis use disorders smoking and vaping cessation cognitive function in schizophrenia


Titel Nach Zitationen sortieren Nach Jahr sortieren Nach Titel sortieren	Zitiert von Zitiert von	Jahr
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised … RM Anthenelli, NL Benowitz, R West, L St Aubin, T McRae, D Lawrence, ... The Lancet 387 (10037), 2507-2520, 2016	1066	2016
Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review ND Volkow, JM Swanson, AE Evins, LE DeLisi, MH Meier, R Gonzalez, ... JAMA psychiatry 73 (3), 292-297, 2016	909	2016
Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis DC Henderson, E Cagliero, PM Copeland, CP Borba, AE Evins, ... Archives of general psychiatry 62 (1), 19-28, 2005	505	2005
The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach M Fava, AE Evins, DJ Dorer, DA Schoenfeld Psychotherapy and psychosomatics 72 (3), 115-127, 2003	501	2003
Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence AC Janes, DA Pizzagalli, S Richardt, BB Frederick, S Chuzi, G Pachas, ... Biological psychiatry 67 (8), 722-729, 2010	471	2010
Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. DC Goff, C Cather, AE Evins, DC Henderson, O Freudenreich, ... Journal of Clinical Psychiatry 66 (2), 183-194, 2005	450	2005
The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls RS Barr, MA Culhane, LE Jubelt, RS Mufti, MA Dyer, AP Weiss, ... Neuropsychopharmacology 33 (3), 480-490, 2008	306	2008
Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness DA Pizzagalli, AE Evins, EC Schetter, MJ Frank, PE Pajtas, DL Santesso, ... Psychopharmacology 196, 221-232, 2008	300	2008
Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study DC Henderson, DD Nguyen, PM Copeland, DL Hayden, CP Borba, ... Journal of Clinical Psychiatry 66 (9), 1116-1121, 2005	265	2005
Optimizing real time fMRI neurofeedback for therapeutic discovery and development LE Stoeckel, KA Garrison, SS Ghosh, P Wighton, CA Hanlon, JM Gilman, ... NeuroImage: Clinical 5, 245-255, 2014	261	2014
A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia AE Evins, VK Mays, C Cather, DC Goff, NA Rigotti, T Tisdale Nicotine & tobacco research 3 (4), 397-403, 2001	258	2001
A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia AE Evins, C Cather, T Deckersbach, O Freudenreich, MA Culhane, ... Journal of clinical psychopharmacology 25 (3), 218-225, 2005	251	2005
Placebo-controlled trial of glycine added to clozapine in schizophrenia AE Evins, SM Fitzgerald, L Wine, R Rosselli, DC Goff American Journal of Psychiatry 157 (5), 826-828, 2000	243	2000
Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial AE Evins, C Cather, SA Pratt, GN Pachas, SS Hoeppner, DC Goff, ... Jama 311 (2), 145-154, 2014	240	2014
A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia DC Goff, DC Henderson, AE Evins, E Amico Biological psychiatry 45 (4), 512-514, 1999	231	1999
A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia AE Evins, C Cather, MA Culhane, A Birnbaum, J Horowitz, E Hsieh, ... Journal of clinical psychopharmacology 27 (4), 380-386, 2007	208	2007
Opioid antagonists for smoking cessation SP David, T Lancaster, LF Stead, AE Evins, JJ Prochaska Cochrane Database of Systematic Reviews, 2013	205	2013
Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight O Freudenreich, C Cather, AE Evins, DC Henderson, DC Goff Journal of Clinical Psychiatry 65 (10), 1372-1376, 2004	196	2004
Initiating pharmacologic treatment in tobacco-dependent adults. An official American Thoracic Society clinical practice guideline FT Leone, Y Zhang, S Evers-Casey, AE Evins, MN Eakin, J Fathi, ... American journal of respiratory and critical care medicine 202 (2), e5-e31, 2020	191	2020
Folate, homocysteine, and negative symptoms in schizophrenia DC Goff, T Bottiglieri, E Arning, V Shih, O Freudenreich, AE Evins, ... American Journal of Psychiatry 161 (9), 1705-1708, 2004	188	2004

Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.

Artikel 1–20

Zitate pro Jahr

Doppelte Zitate

Zusammengeführte Zitate

Koautor hinzufügenKoautoren

Folgen

Zitiert von

Koautoren